Chronic obstructive pulmonary disease . 7: Management of COPD.
A review of the management of COPD is presented, with particular emphasis on the effect on the approach to management of new information which has become available in the 5 years since the BTS guidelines on COPD were published. A major problem is the effective implementation of what is already known, and allocation of the resources necessary to make this available to all who might benefit.
MacNee
W
W
University of Edinburgh, Lothian University NHS Trust, Edinburgh, Scotland, UK. w.macnee@ed.ac.uk
Calverley
P M A
PM
D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D005100:Expectorants / Q000627:therapeutic use; D006801:Humans; D010100:Oxygen / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D016540:Smoking Cessation; D014612:Vaccines / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000975:Antioxidants; D001993:Bronchodilator Agents; D005100:Expectorants; D014612:Vaccines; D010100:Oxygen